ferric nitrilotriacetate has been researched along with Hyperplasia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mori, H; Takahashi, M; Tanaka, T; Williams, GM | 1 |
| Malvaldi, G | 1 |
2 other study(ies) available for ferric nitrilotriacetate and Hyperplasia
| Article | Year |
|---|---|
Exclusion of cellular iron and reduced gamma-glutamyl transpeptidase activity in rat pancreas acinar cell hyperplastic nodules and adenomas induced by azaserine.
Topics: Adenoma; Animals; Azaserine; Ferric Compounds; gamma-Glutamyltransferase; Histocytochemistry; Hyperplasia; Iron; Male; Nitrilotriacetic Acid; Pancreas; Pancreatic Neoplasms; Precancerous Conditions; Rats; Rats, Inbred ACI | 1983 |
Appearance of iron free hyperplastic hepatocytes following ferric nitrilotriacetate and 2-acetaminofluorene sequential administration.
Topics: 2-Acetylaminofluorene; Acetates; Animals; Ferric Compounds; Hyperplasia; Iron; Liver; Male; Nitrilotriacetic Acid; Rats; Rats, Inbred Strains | 1981 |